Nanotechnology and Cardiovascular Medicine

Nanotechnology and Cardiovascular Medicine

Nanotechnology is revolutionizing cardiovascular care through advancements in drug delivery, stent development, disease detection, and regenerative medicine. Nanoparticles enable targeted drug therapies for conditions like atherosclerosis, enhancing treatment while minimizing side effects. Nanotechnology also improves vascular stents by reducing complications and improving integration with tissues. Nanoscale biosensors are enabling early detection of cardiovascular diseases, allowing for timely interventions. In regenerative medicine, nanotechnology supports the creation of biomaterials for cardiac tissue engineering, promoting the regeneration of damaged heart tissue. These innovations are transforming cardiovascular diagnostics and therapy, offering improved outcomes for patients with heart disease.

Related Sessions

Tags



Quick Links

Contact Us

Scitechseries Publishing Limited
71-75, Shelton, Covent Garden
London, WC2H 9JQ

Email: heart@scitechconference.com
Phone: +44 2045874848
WhatsApp: +44 2045250803

© 2022 All Rights Reserved by Scitechseries
Terms and Conditions | Privacy Policy